InvestorsHub Logo
Followers 229
Posts 21458
Boards Moderated 2
Alias Born 08/03/2006

Re: kevgan9 post# 8239

Thursday, 02/11/2021 7:17:49 PM

Thursday, February 11, 2021 7:17:49 PM

Post# of 8426
Synthetic Biologics Announces Washington University School of Medicine in St. Louis IRB Approval of the SYN-004 (ribaxamase) Phase 1b/2a Clinical Protocol

December 22, 2020
https://finance.yahoo.com/news/synthetic-biologics-announces-washington-university-120000078.html


2,219,019 shares of Common Stock issuable upon exercise of warrants* (see Item 4)

Let's see some real progress with SYN. $3 ++++ potential imo.


Do your research! Play the TA. All posts are my opinion.
Is fundamental trading dead?

"We hope not." Richard Dennis

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TOVX News